Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
Andrzej Lange,
Emilia Jaskula,
Janusz Lange,
Grzegorz Dworacki,
Dorota Nowak,
Aleksandra Simiczyjew,
Monika Mordak-Domagala,
Mariola Sedzimirska
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow